| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4023593
[patent_doc_number] => 05925682
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-20
[patent_title] => 'Epinephrine as inhibitor of cancerous tumors'
[patent_app_type] => 1
[patent_app_number] => 8/751336
[patent_app_country] => US
[patent_app_date] => 1996-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 3637
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/925/05925682.pdf
[firstpage_image] =>[orig_patent_app_number] => 751336
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/751336 | Epinephrine as inhibitor of cancerous tumors | Nov 17, 1996 | Issued |
Array
(
[id] => 3996858
[patent_doc_number] => 05985924
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-16
[patent_title] => 'Metastasis suppressory agents'
[patent_app_type] => 1
[patent_app_number] => 8/749403
[patent_app_country] => US
[patent_app_date] => 1996-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1343
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/985/05985924.pdf
[firstpage_image] =>[orig_patent_app_number] => 749403
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/749403 | Metastasis suppressory agents | Nov 14, 1996 | Issued |
| 08/742000 | SYNERGISTIC RAPAMYCIN COMBINATION | Oct 30, 1996 | Abandoned |
Array
(
[id] => 4103828
[patent_doc_number] => 06056964
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-02
[patent_title] => 'Immunotherapeutic agent and its use'
[patent_app_type] => 1
[patent_app_number] => 8/716189
[patent_app_country] => US
[patent_app_date] => 1996-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2853
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/056/06056964.pdf
[firstpage_image] =>[orig_patent_app_number] => 716189
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/716189 | Immunotherapeutic agent and its use | Oct 24, 1996 | Issued |
Array
(
[id] => 3861759
[patent_doc_number] => 05795871
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-18
[patent_title] => 'Pharmaceutical composition for treatment of non-small cell lung cancer'
[patent_app_type] => 1
[patent_app_number] => 8/727547
[patent_app_country] => US
[patent_app_date] => 1996-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4931
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 189
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/795/05795871.pdf
[firstpage_image] =>[orig_patent_app_number] => 727547
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/727547 | Pharmaceutical composition for treatment of non-small cell lung cancer | Oct 22, 1996 | Issued |
Array
(
[id] => 4085469
[patent_doc_number] => 06162792
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-19
[patent_title] => 'Use of spiramycin for treating gastrointestinal disorders caused by H. pylori'
[patent_app_type] => 1
[patent_app_number] => 8/727466
[patent_app_country] => US
[patent_app_date] => 1996-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1654
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/162/06162792.pdf
[firstpage_image] =>[orig_patent_app_number] => 727466
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/727466 | Use of spiramycin for treating gastrointestinal disorders caused by H. pylori | Oct 21, 1996 | Issued |
Array
(
[id] => 3808067
[patent_doc_number] => 05854240
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-29
[patent_title] => 'Methylene blue for the treatment or prophylaxis of encephalopathy caused by ifosfamide'
[patent_app_type] => 1
[patent_app_number] => 8/646292
[patent_app_country] => US
[patent_app_date] => 1996-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 7102
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/854/05854240.pdf
[firstpage_image] =>[orig_patent_app_number] => 646292
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/646292 | Methylene blue for the treatment or prophylaxis of encephalopathy caused by ifosfamide | Oct 17, 1996 | Issued |
Array
(
[id] => 3946240
[patent_doc_number] => 05977109
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-02
[patent_title] => 'Method for stabilizing compound DX-52-1 and lyophilized composition thereof'
[patent_app_type] => 1
[patent_app_number] => 8/732384
[patent_app_country] => US
[patent_app_date] => 1996-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1947
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/977/05977109.pdf
[firstpage_image] =>[orig_patent_app_number] => 732384
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/732384 | Method for stabilizing compound DX-52-1 and lyophilized composition thereof | Oct 15, 1996 | Issued |
Array
(
[id] => 3967269
[patent_doc_number] => 05886033
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-23
[patent_title] => 'Use of isoxazole and crotonamide derivatives for the treatment of carcinomatous disorders'
[patent_app_type] => 1
[patent_app_number] => 8/733050
[patent_app_country] => US
[patent_app_date] => 1996-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3187
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/886/05886033.pdf
[firstpage_image] =>[orig_patent_app_number] => 733050
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/733050 | Use of isoxazole and crotonamide derivatives for the treatment of carcinomatous disorders | Oct 15, 1996 | Issued |
Array
(
[id] => 4175271
[patent_doc_number] => 06083979
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-04
[patent_title] => 'Geranylgeraniol/lovastatin: a novel approach to blocking cancer transformation without cytotoxicity'
[patent_app_type] => 1
[patent_app_number] => 8/728314
[patent_app_country] => US
[patent_app_date] => 1996-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 7294
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/083/06083979.pdf
[firstpage_image] =>[orig_patent_app_number] => 728314
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/728314 | Geranylgeraniol/lovastatin: a novel approach to blocking cancer transformation without cytotoxicity | Oct 8, 1996 | Issued |
Array
(
[id] => 3945969
[patent_doc_number] => 05977092
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-02
[patent_title] => 'Drug for curing/ameliorating concomitant syndrome of tumor'
[patent_app_type] => 1
[patent_app_number] => 8/727651
[patent_app_country] => US
[patent_app_date] => 1996-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2470
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/977/05977092.pdf
[firstpage_image] =>[orig_patent_app_number] => 727651
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/727651 | Drug for curing/ameliorating concomitant syndrome of tumor | Oct 8, 1996 | Issued |
| 08/721225 | THERAPEUTIC USES OF 4QUINOLINE CARBOXYLIC ACID DERIVATIVES | Sep 25, 1996 | Abandoned |
| 08/719229 | METHODS OF REDUCING INTRACELLULAR POLYAMINE LEVELS | Sep 24, 1996 | Abandoned |
Array
(
[id] => 3689294
[patent_doc_number] => 05691355
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-25
[patent_title] => 'Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs'
[patent_app_type] => 1
[patent_app_number] => 8/718841
[patent_app_country] => US
[patent_app_date] => 1996-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3556
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 182
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/691/05691355.pdf
[firstpage_image] =>[orig_patent_app_number] => 718841
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/718841 | Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs | Sep 23, 1996 | Issued |
Array
(
[id] => 3833450
[patent_doc_number] => 05814625
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-29
[patent_title] => 'Chemoprevention of metachronous adenomatous colorectal polyps'
[patent_app_type] => 1
[patent_app_number] => 8/717556
[patent_app_country] => US
[patent_app_date] => 1996-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6187
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/814/05814625.pdf
[firstpage_image] =>[orig_patent_app_number] => 717556
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/717556 | Chemoprevention of metachronous adenomatous colorectal polyps | Sep 22, 1996 | Issued |
Array
(
[id] => 3728962
[patent_doc_number] => 05670537
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-23
[patent_title] => 'Method for effecting tumor regression with a low dose, short infusion taxol regimen'
[patent_app_type] => 1
[patent_app_number] => 8/715914
[patent_app_country] => US
[patent_app_date] => 1996-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7685
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/670/05670537.pdf
[firstpage_image] =>[orig_patent_app_number] => 715914
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/715914 | Method for effecting tumor regression with a low dose, short infusion taxol regimen | Sep 18, 1996 | Issued |
Array
(
[id] => 4183226
[patent_doc_number] => 06020360
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-01
[patent_title] => 'Anticancer property of dithiolopyrrolones'
[patent_app_type] => 1
[patent_app_number] => 8/716593
[patent_app_country] => US
[patent_app_date] => 1996-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2605
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/020/06020360.pdf
[firstpage_image] =>[orig_patent_app_number] => 716593
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/716593 | Anticancer property of dithiolopyrrolones | Sep 17, 1996 | Issued |
Array
(
[id] => 4239887
[patent_doc_number] => 06080751
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-06-27
[patent_title] => 'Method for treating pancreatic cancer in humans with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof'
[patent_app_type] => 1
[patent_app_number] => 8/713392
[patent_app_country] => US
[patent_app_date] => 1996-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2919
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/080/06080751.pdf
[firstpage_image] =>[orig_patent_app_number] => 713392
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/713392 | Method for treating pancreatic cancer in humans with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof | Sep 12, 1996 | Issued |
| 08/706634 | COMPOSITION AND METHOD FOR TREATING AND PREVENTING NEOPLASTIC DISEASES AND TREATING OF CYSTIC FIBROSIS | Sep 5, 1996 | Abandoned |
Array
(
[id] => 3975963
[patent_doc_number] => 05916911
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-06-29
[patent_title] => 'Amino ceramide--like compounds and therapeutic methods of use'
[patent_app_type] => 1
[patent_app_number] => 8/708574
[patent_app_country] => US
[patent_app_date] => 1996-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 3
[patent_no_of_words] => 10606
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/916/05916911.pdf
[firstpage_image] =>[orig_patent_app_number] => 708574
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/708574 | Amino ceramide--like compounds and therapeutic methods of use | Sep 4, 1996 | Issued |